Dr Linda Mileshkin

Current national competitive grants*

2012

PORTEC-3 - the role of adjuvant chemotherapy in high-risk endometrial cancer
Mileshkin L, Khaw P, Stockler M, Brand A, Martyn J, Sjoquist K, Creutzberg C, Quinn M
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($300,878 over 3 years)

* Grants administered through the University of Sydney

Send a note

Recipient	Linda Mileshkin
Your name
Your email address
Subject
Message
Verification	In order to prevent spam email, you will need to enter the verification code that appears in the red coloured box to the left.